Paper36911549
2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Huang WC and 28 others. Acta Cardiol Sin, 2023. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Papers, record 36911549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911549
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References148
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34065585 | Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort. | Healthcare (Basel) | 2021 | https://conductscience.org/library/papers/34065585 | PubMed |
| 2 | 21546436 | Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study. | Chest | 2011 | https://conductscience.org/library/papers/21546436 | PubMed |
| 3 | 28849593 | Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/28849593 | PubMed |
| 4 | 28775050 | Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. | Eur Respir J | 2017 | https://conductscience.org/library/papers/28775050 | PubMed |
| 5 | 29419347 | The prognosis of pulmonary arterial hypertension associated with primary Sjögren's syndrome: a cohort study. | Lupus | 2018 | https://conductscience.org/library/papers/29419347 | PubMed |
| 6 | 28615037 | High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center. | Arthritis Res Ther | 2017 | https://conductscience.org/library/papers/28615037 | PubMed |
| 7 | 16840400 | Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. | Chest | 2006 | https://conductscience.org/library/papers/16840400 | PubMed |
| 8 | 16793845 | Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/16793845 | PubMed |
| 9 | 18931333 | Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. | Am J Respir Crit Care Med | 2009 | https://conductscience.org/library/papers/18931333 | PubMed |
| 10 | 31416927 | Nailfold Videocapillaroscopy in Systemic Sclerosis-related Pulmonary Arterial Hypertension: A Systematic Literature Review. | J Rheumatol | 2020 | https://conductscience.org/library/papers/31416927 | PubMed |
| 11 | 34616495 | Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review. | Ther Adv Musculoskelet Dis | 2021 | https://conductscience.org/library/papers/34616495 | PubMed |
| 12 | 16014687 | Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/16014687 | PubMed |
| 13 | 14736539 | The endothelin system in pulmonary arterial hypertension. | Cardiovasc Res | 2004 | https://conductscience.org/library/papers/14736539 | PubMed |
| 14 | 33773120 | Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/33773120 | PubMed |
| 15 | 24815795 | Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension. | J Heart Lung Transplant | 2014 | https://conductscience.org/library/papers/24815795 | PubMed |
| 16 | 33547781 | Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study. | Rheumatology (Oxford) | 2021 | https://conductscience.org/library/papers/33547781 | PubMed |
| 17 | 20507945 | Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. | Chest | 2010 | https://conductscience.org/library/papers/20507945 | PubMed |
| 18 | 19837821 | Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. | Chest | 2010 | https://conductscience.org/library/papers/19837821 | PubMed |
| 19 | 30545980 | Pulmonary hypertension in chronic lung disease and hypoxia. | Eur Respir J | 2019 | https://conductscience.org/library/papers/30545980 | PubMed |
| 20 | 31511227 | Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/31511227 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780711 | Long-Term Survival in Pulmonary Arterial Hypertension with Different Etiologies: A Single-Center Experience. | Acta Cardiol Sin | 2026 | https://conductscience.org/library/papers/42780711 | PubMed |
| 42113392 | The presence of anti-Ro52/SSA antibodies may predict concomitant pulmonary hypertension and poorer survival in patients with connective tissue disease-associated interstitial lung disease. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42113392 | PubMed |
| 41167678 | Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report. | In Vivo | 2025 | https://conductscience.org/library/papers/41167678 | PubMed |
| 41080302 | Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence. | Cureus | 2025 | https://conductscience.org/library/papers/41080302 | PubMed |
| 40880769 | A comparative analysis of cardiopulmonary features in patients with systemic sclerosis and mixed connective tissue disease: results from SOPHIE registry. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40880769 | PubMed |
| 40563413 | Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review. | Biomolecules | 2025 | https://conductscience.org/library/papers/40563413 | PubMed |
| 39776929 | 2025 Expert Consensus Recommendations for the Diagnostic Requirements in Routine Practices of Transthoracic Echocardiography. | Acta Cardiol Sin | 2025 | https://conductscience.org/library/papers/39776929 | PubMed |
| 37886934 | Biomarkers in Systemic Sclerosis: An Overview. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37886934 | PubMed |
| 37868834 | Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37868834 | PubMed |
| 36911545 | Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management. | Acta Cardiol Sin | 2023 | https://conductscience.org/library/papers/36911545 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911549
GET https://conductscience.org/api/papers/v1/36911549/authors?page=2